We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Pricesmart
PSMT
$5.9B
| $2.55M | 0.01% |
44,300
+31,100
| +236% | +$2.01M |
|
1052
Amphastar Pharmaceuticals
AMPH
$888M
| $2.55M | 0.01% |
90,600
-20,800
| -19% | -$679K |
|
1053
Oil States International
OIS
$483M
| $2.54M | 0.01% |
652,455
+61,900
| +10% | +$296K |
|
1054
Hayward Holdings
HAYW
$3.28B
| $2.54M | 0.01% |
285,900
+17,400
| +6% | +$205K |
|
1055
Armstrong World Industries
AWI
$7.62B
| $2.53M | 0.01% |
31,900
+1,700
| +6% | +$144K |
|
1056
Crinetics Pharmaceuticals
CRNX
$8.88B
| $2.52M | 0.01% |
128,500
-1,300
| -1% | -$26.5K |
|
|
AAT
1057
American Assets Trust
AAT
$1.48B
| $2.51M | 0.01% |
97,729
+50,500
| +107% | +$1.45M |
|
|
ABTX
1058
DELISTED
Allegiance Bancshares
ABTX
| $2.51M | 0.01% |
60,300
+16,800
| +39% | +$718K |
|
1059
Valaris
VAL
$5.16B
| $2.5M | 0.01% |
51,100
-15,100
| -23% | -$724K |
|
|
HTLF
1060
DELISTED
Heartland Financial USA, Inc.
HTLF
| $2.49M | 0.01% |
57,500
+4,900
| +9% | +$217K |
|
1061
NewtekOne
NEWT
$425M
| $2.48M | 0.01% |
152,200
-53,400
| -26% | -$1.09M |
|
1062
Tenet Healthcare
THC
$22.6B
| $2.48M | 0.01% |
48,100
-49,800
| -51% | -$2.96M |
|
1063
Standex International
SXI
$3.56B
| $2.47M | 0.01% |
30,263
+1,300
| +4% | +$116K |
|
1064
Viking Therapeutics
VKTX
$3.93B
| $2.47M | 0.01% |
906,628
-214,400
| -19% | -$702K |
|
|
KNBE
1065
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $2.46M | 0.01% |
+118,400
| New | +$2.18M |
|
1066
RE/MAX Holdings
RMAX
$206M
| $2.45M | 0.01% |
129,700
-18,500
| -12% | -$439K |
|
1067
BridgeBio Pharma
BBIO
$16.8B
| $2.45M | 0.01% |
246,700
+205,420
| +498% | +$2.13M |
|
1068
Phillips 66
PSX
$82.5B
| $2.45M | 0.01% |
30,300
-390,399
| -93% | -$33.3M |
|
|
CCXI
1069
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.45M | 0.01% |
47,341
-109,300
| -70% | -$4.52M |
|
1070
Ingevity
NGVT
$2.59B
| $2.44M | 0.01% |
40,300
+7,100
| +21% | +$476K |
|
1071
FuelCell Energy
FCEL
$1.57B
| $2.44M | 0.01% |
23,870
-1,567
| -6% | -$188K |
|
|
SVC
1072
Service Properties Trust
SVC
$1.09B
| $2.44M | 0.01% |
93,940
-8,260
| -8% | -$274K |
|
1073
Envista
NVST
$4.39B
| $2.43M | 0.01% |
+74,000
| New | +$2.8M |
|
|
AVID
1074
DELISTED
Avid Technology Inc
AVID
| $2.42M | 0.01% |
104,200
-159,500
| -60% | -$4.16M |
|
1075
Enanta Pharmaceuticals
ENTA
$367M
| $2.42M | 0.01% |
46,700
-10,900
| -19% | -$637K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.